Uptake and Patient Perspectives on Additional Testing for Novel Disease-Associated Genes: Lessons from a PAH Cohort

Background: Pulmonary arterial hypertension (PAH) has an identifiable genetic cause in 5% of all PAH cases. Due to health benefits conferred by the early detection of PAH and the recent identification of additional PAH-associated genes, we decided to offer (extended) genetic testing to all incident...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Samara M. A., van de Heuvel, Lieke M., Houweling, Arjan C., van Tintelen, J. Peter, de Man, Frances S., Vonk Noordegraaf, Anton, Jan Bogaard, Harm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536181/
https://www.ncbi.nlm.nih.gov/pubmed/34680935
http://dx.doi.org/10.3390/genes12101540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536181/
https://www.ncbi.nlm.nih.gov/pubmed/34680935
http://dx.doi.org/10.3390/genes12101540

Ejemplares similares